Norman Wasel

2.7k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

Norman Wasel is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Norman Wasel has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 12 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Norman Wasel's work include Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (9 papers) and Autoimmune Bullous Skin Diseases (8 papers). Norman Wasel is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (9 papers) and Autoimmune Bullous Skin Diseases (8 papers). Norman Wasel collaborates with scholars based in Canada, United States and Switzerland. Norman Wasel's co-authors include Kim Papp, Richard G. Langley, Stephen K. Tyring, L. Puig, Tsen‐Fang Tsai, Boni E. Elewski, C.E.M. Griffiths, Hidemi Nakagawa, Kristian Reich and Mark Lebwohl and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Academy of Dermatology.

In The Last Decade

Norman Wasel

20 papers receiving 1.9k citations

Hit Papers

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 ... 2014 2026 2018 2022 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
    2014 1.5k citations Richard G. Langley, Boni E. Elewski et al. New England Journal of Medicine profile →

Peers

Norman Wasel
Marianne Notter Switzerland
Isabelle Hampele United States
Emily Edson‐Heredia United States
Michael Song United States
Kristina Callis Duffin United States
Gregory Kricorian United States
Melodie Young United States
Martin M. Okun United States
Marco Galluzzo Italy
Yoshinori Umezawa Japan
Marianne Notter Switzerland
Norman Wasel
Citations per year, relative to Norman Wasel Norman Wasel (= 1×) peers Marianne Notter

Countries citing papers authored by Norman Wasel

Since Specialization
Citations

This map shows the geographic impact of Norman Wasel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Wasel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Wasel more than expected).

Fields of papers citing papers by Norman Wasel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Wasel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Wasel. The network helps show where Norman Wasel may publish in the future.

Co-authorship network of co-authors of Norman Wasel

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Wasel. A scholar is included among the top collaborators of Norman Wasel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Wasel. Norman Wasel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wasel, Norman, Diamant Thaçi, Lars E. French, et al.. (2020). Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S). Dermatology and Therapy. 10(4). 663–670. 24 indexed citations
2.
3.
Papp, Kim, Wayne Gulliver, Charles Lynde, et al.. (2016). 2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009. Journal of Cutaneous Medicine and Surgery. 20(5). 375–431. 26 indexed citations
4.
Langley, Richard G., Boni E. Elewski, Mark Lebwohl, et al.. (2014). Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials. New England Journal of Medicine. 371(4). 326–338. 1488 indexed citations breakdown →
5.
Brodmerkel, Carrie, Eric Wadman, Richard G. Langley, et al.. (2013). Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.. PubMed. 12(10). 1122–9. 51 indexed citations
6.
Poulin, Yves, et al.. (2012). Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.. PubMed. 58(7). e390–400. 4 indexed citations
7.
Poulin, Yves, et al.. (2010). A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. International Journal of Dermatology. 49(12). 1368–1375. 36 indexed citations
8.
Leonardi, Craig L., Richard G. Langley, Kim Papp, et al.. (2010). Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet. Archives of Dermatology. 147(4). 429–429. 84 indexed citations
9.
Papp, Kim, et al.. (2010). Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population. Journal of Cutaneous Medicine and Surgery. 14(4). 167–174. 13 indexed citations
10.
Long, Richard, et al.. (2009). Lupus Vulgaris Occurring in a Locus Minoris Resistentiae. Journal of Cutaneous Medicine and Surgery. 13(6). 313–316. 1 indexed citations
11.
Wasel, Norman, et al.. (2009). A Canadian Self-Administered Online Survey to Evaluate the Impact of Moderate-to-Severe Psoriasis among Patients. Journal of Cutaneous Medicine and Surgery. 13(6). 294–302. 21 indexed citations
12.
Papp, Kim, Robert Bissonnette, Norman Wasel, et al.. (2008). Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study. The Lancet. 371(9621). 1337–1342. 61 indexed citations
13.
Barankin, Benjamin, et al.. (2005). Successful Hair Transplant of Eyebrow Alopecia Areata. Journal of Cutaneous Medicine and Surgery. 9(4). 162–164. 16 indexed citations
14.
Kerkhof, P.C.M. van de, Norman Wasel, Knud Kragballe, F. Cambazard, & Scott Murray. (2005). A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis vulgaris regardless of Baseline Disease Severity. Dermatology. 210(4). 294–299. 21 indexed citations
15.
Barankin, Benjamin, et al.. (2005). Skin disorders in Ashkenazi Jews: a review. International Journal of Dermatology. 44(8). 630–635. 2 indexed citations
16.
Barankin, Benjamin, et al.. (2005). Successful Hair Transplant of Eyebrow Alopecia Areata. Journal of Cutaneous Medicine and Surgery. 9(4). 162–164. 7 indexed citations
17.
Wasel, Norman, Halliday Idikio, Gordon Lees, Alfons Krol, & Andrew N. Lin. (2000). Junctional Epidermolysis Bullosa with Pyloric Stenosis Presenting with Electron Microscopic Findings Suggestive of Epidermolysis Bullosa Simplex. Pediatric Dermatology. 17(5). 395–398. 3 indexed citations
18.
Wasel, Norman, et al.. (1998). Minocycline-Lnduced Cutaneous Pigmentation. Journal of Cutaneous Medicine and Surgery. 3(2). 105–108. 6 indexed citations
19.
Triggs‐Raine, Barbara L., Manon Richard, Norman Wasel, E M Prence, & Marvin R. Natowicz. (1995). Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.. PubMed. 56(4). 870–9. 23 indexed citations
20.
Broughton, Ross & Norman Wasel. (1990). A text-stimuli presentation manager for the IBM PC with ipsatization correction for response sets and reaction times. Behavior Research Methods, Instruments, & Computers. 22(4). 421–423. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Notter Breakdown of academic impact, for papers by Isabelle Hampele Breakdown of academic impact, for papers by Emily Edson‐Heredia Breakdown of academic impact, for papers by Michael Song Breakdown of academic impact, for papers by Kristina Callis Duffin Breakdown of academic impact, for papers by Gregory Kricorian Breakdown of academic impact, for papers by Melodie Young Breakdown of academic impact, for papers by Martin M. Okun Breakdown of academic impact, for papers by Marco Galluzzo Breakdown of academic impact, for papers by Yoshinori Umezawa
Rankless by CCL
2026